SAB BIOTHERAPEUTICS, INC. (SABS) Net income 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$13.3MFY2025 · since FY2020: $20.1M → $13.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $13.3M | +138.9% |
| FY2024 | -$34.1M | +19.2% |
| FY2023 | -$42.2M | -125.1% |
| FY2022 | -$18.7M | -9.3% |
| FY2021 | -$17.1M | -185.2% |
| FY2020 | $20.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SABS financial trends
SABS RevenueSABS Net marginSABS Gross profitSABS Gross marginSABS Operating incomeSABS Operating marginSABS Operating cash flowSABS Free cash flowSABS Capital expendituresSABS Return on equitySABS Stock buybacksSABS Dividends paidSABS Total assetsSABS Total liabilitiesSABS Shareholders’ equitySABS overview →